• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
water filter
WATER FILTER FOR WATER PURIFIER
DUST BAG
Small dust filter
HUMIDIFIER FILTER
Oil fume adsorption filter

Israel Says it Sent ‘Completely Normal’ Vaccines to Palestinians

firstwordpharmaJune 21, 2021

Tag: Vaccine , Pfizer , Health Ministry

Israel's Health Ministry said that the first batch of Pfizer's vaccine Israel sent to the Palestinian Authority as part of a larger swap deal was "completely normal" and identical to the vaccines being given to Israeli citizens, Bloomberg reported.

Israel Says it Sent ‘Completely Normal’ Vaccines to Palestinians

The Palestinian Authority cancelled its exchange agreement with Israel as the doses were set to expire this month, leaving its health ministry insufficient time to use them.

However, the ministry said it sent vaccines with expiration dates that were "known, agreed upon and in accordance with the agreement between the parties."

Previous:Eisai, BMS Enter Global Anticancer ADC Alliance

Next:Solvias Acquires Chemic Labs

Related News

Thrombolytic Science Announces FDA’s IND Clearance of Mutant Prourokinase for the Treatment of Thrombotic Diseases

PharmaSourcesOctober 15, 2024

Thrombolytic Science, LLC (TSI), announced today that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for mutant prourokinase, a recombinant fibrinolytic pro-enzyme.

Eleva Appoints Dr. Elisabeth Lackner to its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization

PharmaSourcesOctober 15, 2024

BrainDos™ Formulated Dual GIP/GLP-1 Receptor Agonist Tirzepatide Outperforms Tirzepatide Solution (Mounjaro®) in Preclinical Study

PharmaSourcesOctober 15, 2024

Israel Says it Sent ‘Completely Normal’ Vaccines to Palestinians | Pharmasources.com

BD and ten23 health® Partner to Advance Efficiency and Quality in Aseptic Manufacturing with RFID-Enabled Prefillable Syringes

PharmaSourcesOctober 15, 2024

BD and ten23 health today announced a collaboration to develop a new way to track prefillable syringes (PFS) using RFID technology.

You may like
More>>

Recombinant Hepatitis B Vaccine

Recombinant Hepatitis B Vaccine
Good immunogenicity performance Influenza Vaccine (Split virion)

Good immunogenicity performance Influenza Vaccine (Split virion)
Hualan Biological inactivated influenza vaccine

Hualan Biological inactivated influenza vaccine
Influenza Vaccine China-Hualan

Influenza Vaccine China-Hualan
*trivalent flu vaccine

*trivalent flu vaccine
Group ACYW135 Meningococcal Polysaccharide Vaccine with lower side effect by hualan biological

Group ACYW135 Meningococcal Polysaccharide Vaccine with lower side effect by hualan biological
Inactivated Influenza Vaccine(Split Virion) manufactured by Hualan Bio

Inactivated Influenza Vaccine(Split Virion) manufactured by Hualan Bio
High quality of Influenza Vaccine (Split Virion), Inactivated, Quadrivalent

High quality of Influenza Vaccine (Split Virion), Inactivated, Quadrivalent
Hualan Influenza Vaccine(Split Virion),Inactivated

Hualan Influenza Vaccine(Split Virion),Inactivated
Poliomyelitis (Live) Vaccine Type I Type III (Human Diploid Cell), Oral

Poliomyelitis (Live) Vaccine Type I Type III (Human Diploid Cell), Oral

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service